In Silico Screening of Triphala Churna against Bacterial Agents

Jump To References Section

Authors

  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRMIST, Kattankulathur, Kancheepuram – 603203, Tamil Nadu ,IN
  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRMIST, Kattankulathur, Kancheepuram – 603203, Tamil Nadu ,IN
  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRMIST, Kattankulathur, Kancheepuram – 603203, Tamil Nadu ,IN
  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRMIST, Kattankulathur, Kancheepuram – 603203, Tamil Nadu ,IN

DOI:

https://doi.org/10.18311/jnr/2022/28664

Keywords:

Anti-bacterial Activity, InhA, Molecular Docking, Terflavin B, Triphala Churna

Abstract

Triphala Churna consisting Triphala and its constituents have been revealed to have antibacterial properties against human pathogens. The phenolic ring of phytochemicals has been confirmed to be toxic against microorganisms and hence responsible for antibacterial effect. It has also been found to possess antimicrobial, anti-inflammatory, anti-oxidant, and other properties. The objective of this project is to investigate which bioactive compounds of Triphala churna have antibacterial action and can protect humans from infection. The majority of the molecules in phytochemical examination were positive for ethanolic and acetone extracts and the physicochemical characteristics were within the acceptable limits. In silico data clearly explains that the compounds of Triphala churna follows Lipinski’s rule of five. The toxicity profile and ADME parameters of the compounds revealed that most of the compounds were nontoxic towards carcinogenicity, mutagenicity, and reproductive effect. Based on the energy type of interaction between these molecules and the study protein, molecular docking revealed that the three compounds from Triphala churna own the highest docking score against InhA protein: Terflavin B (-9.67 Kcal/mol), Ellagic acid (-9.37 Kcal/mol), and Corilagin (-8.57 Kcal/mol).

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2022-04-19

How to Cite

Dhivya, L. S., Haritha, M., Anjana, G. V., & Priya, D. (2022). <i>In Silico</i> Screening of Triphala Churna against Bacterial Agents. Journal of Natural Remedies, 22(2), 221–232. https://doi.org/10.18311/jnr/2022/28664

Issue

Section

Research Articles
Received 2021-09-20
Accepted 2022-02-22
Published 2022-04-19

 

References

Peterson CT, Denniston K, Chopra D. Therapeutic uses of Triphala in Ayurvedic medicine. J Altern Complement Med. 2017; 23(8):607–14. https://doi.org/10.1089/ acm.2017.0083. PMid:28696777. PMCid:PMC5567597

Nayak K, Patil A, Vishnuprasad S, Nayak DM. Antibacterial effect of triphala churna against common wound pathogens. Int J Curr Res. 2015; 7(01):12074–7.

Singh RK, Gupta R, Dwivedi N. A review on antimicrobial activities of triphala and its constituents. World J Pharm Pharm Sci. 2016; 5(4):535–58.

Rao PP. Antioxidant effect of Triphala - Critical review. J Ayurveda Integr Med. 2017; 2(1):213–19. https://doi.org/10.21760/jaims.v2i1.7513

Prabu D, Kirubanandan S, Ponnudurai K, Nappinnai M, Jinu A, Renganathan S. Anti-inflammatory and analgesic activities of methanol extract of Triphala - A poly herbal formulation. Orient Pharm Exp Med. 2008; 8(4):423–9. https://doi.org/10.3742/OPEM.2008.8.4.423

Chouhan B, Kumawat R, Kotecha M, Ramamurthy A, Nathani S. Triphala: A comprehensive ayurvedic review triphala: A comprehensive ayurvedic review. Int. J. Ayurveda Res. 2013; 4(4):612–17. https://doi.org/10.7897/2277-4343.04433

Varma SR, Sivaprakasam TO, Mishra A, et al. Protective effects of Triphala on dermal fibroblasts and human keratinocytes. PLoS One. 2016; 11(1):e0145921. https:// doi.org/10.1371/journal.pone.0145921. PMid:26731545 PMCid:PMC4711708

Belapurkar P, Goyal P, Tiwari-Barua P. Immunomodulatory effects of triphala and its individual constituents: A review. Indian J Pharm Sci. 2014; 76(6):467–75.

Prasad S, Srivastava S. Oxidative stress and cancer: Chemopreventive and therapeutic role of triphala Antioxidants. 2020; 9(1):72. https://doi.org/10.3390/antiox9010072. PMid:31941067 PMCid:PMC7022920

Murthy M. Anticancer and pro?apoptotic effects of Triphala extract in human breast cancer MCF?7 cells. FASEB J. 2018; 32(S1). https://doi.org/10.1096/fasebj.2018.32.1_supplement. 151.2

Chainani S, Siddana S, Reddy C, Thippeswamy M, Maurya M, Rudraswamy S. Antimicrobial activity of Triphala on Lactobacilli and Candida albicans: An in vitro study. J Orofac Sci. 2015; 7(2):104. https://doi.org/10.4103/0975-8844.169757

Manoraj A, Thevanesam V, Bandara BMR, Ekanayake A, Liyanapathirana V. Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates. BMC Complement Altern Med. 2019; 19(1):199. https://doi.org/10.1186/s12906-019-2618-1. PMid:31375093 PMCid:PMC6679468

Rao P. Antioxidant effect of Triphala - Critical review. J Ayurveda Integr Med. 2017: 2(1). https://doi.org/10.21760/jaims.v2i1.7513

Patil SG, Deshmukh AA, Padol AR, Kale DB. In vitro antimicrobial activity of Emblica officinalis fruit by tube dilution method. Toxicol Appl Pharmacol. 2012; 2:49–51

Mahalakshmi K, Prabhakar J, Sukumaran VG. Antibacterial activity of Triphala, GTP and curcumin on Enterococci faecalis. Biomedicine. 2006; 26:43–6.

Sumathi P, Parvathi A. Antibacterial potential of the three medicinal fruits used in Triphala: An Ayurvedic formulation. J. Med. Plants Res. 2010; 4:1682–5.

Zareen N, Jaiganesh R. Antimicrobial effect of Triphala on oral microbes - An in vivo study. Drug Invent Today. 2019; 11(2).

Chainani S, Siddana S, Reddy C, Thippeswamy M, Maurya M, Rudraswamy S. Antimicrobial activity of Triphala on Lactobacilli and Candida albicans: An in vitro study. J Orofac Sci. 2015; 7(2):104. https://doi.org/10.4103/0975-8844.169757

Kumar NS, Nair AS, Murali M, Devi PSS. Qualitative phytochemical analysis of triphala extracts. J. Pharmacogn Phytochem. 2017; 6(3):248–51.

Duchowicz PR, Talevi A, Bellera C, Bruno-Blanch LE, Castro EA. Application of descriptors based on Lipinski’s rules in the QSPR study of aqueous solubilities. Bioorg Med Chem. 2007; 15(11):3711–9. https://doi.org/10.1016/j.bmc.2007.03.044. PMid:17418580

Pires DEV, Blundell TL, Ascher DB. PkCSM: Predicting smallmolecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015; 58(9):4066–72. https://doi.org/10.1021/acs.jmedchem.5b00104. PMid:25860834 PMCid:PMC4434528

Kumar N, Mishra SS, Sharma CS, Singh HP, Singh H. In silico pharmacokinetic, bioactivity and toxicity evaluation of some selected anti-ulcer agents. Int J Pharm Sci Drug Res. 2017; 9(2). https://doi.org/10.25004/IJPSDR.2017.090205